Skip to main content
. 2023 Feb 1;15(3):743. doi: 10.3390/nu15030743

Figure 5.

Figure 5

SFN improves hepatic inflammation by inhibiting the TLR4/MyD88/NF-κB signaling pathway in HFHFr mice. (A) Levels of LPS in the liver (n = 6). (BF) The protein expression of TLR4, MyD88, NF–κB p65, and phosphorylation of NF–κB p65 in the liver were detected by Western blot (n = 3). Data are shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 compared with HFHFr.